Aussie Court Rules For Sirtex In Five-Year Dispute With Cancer Drug Doc
This article was originally published in PharmAsia News
Executive SummaryAn Australian court ruled Sirtex Medical may recover from its former director the cost of five years of litigation with the University of Western Australia over invention ownership of a cancer drug
You may also be interested in...
San Francisco-based digital health start-up Steady Health has launched the first "virtual" full-service diabetes clinic for patients in California. See what Henrik Berggren, CEO and founder of Steady Health, said about it here.
The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.